Mitochondrial encephalomyopathies;Encefalomiopatías mitocondriales

Revista de Neurologia

Volumn 31, Issue 3, 2000, Pages 263-282

  Castro Gago, M ^a   Novo Rodríguez, Ma I ^a   Pintos Martinez E ^a   Campos, Y ^b   Arenas, J ^b   Eiris Punal J ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Adolescence; Childhood; Lactic acid; Mitochondrial encephalomyopathies; Mitochondrial genetic; Ragged red fibers

Indexed keywords

LACTIC ACID; MITOCHONDRIAL DNA;

BRAIN; ELECTRON TRANSPORT; GENETICS; HUMAN; METABOLISM; MITOCHONDRIAL ENCEPHALOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; POINT MUTATION; REVIEW;

BRAIN; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; HUMANS; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MITOCHONDRIAL ENCEPHALOMYOPATHIES; POINT MUTATION;

EID: 0034241059     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3103.2000074     Document Type: Conference Paper

References (240)

1. Attardi G, Schatz G. Biogenesis of mitochondria. Ann Rev Cell Biol 1988; 4: 289-333.
2. Enríquez JA, Martínez-Azorín F, Garesse R, López-Pérez MJ, Pérez-Martos A, Bornstein B, et al. Sistema genético mitocondrial humano. Rev Neurol 1998; 26 (Supl 1): S21-6.
3. De Vivo DC. The expanding clinical spectrum of mitochondrial diseases. Brain Dev 1993; 15: 1-22.
4. DiMauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol 1993; 50: 1197-208.
5. DiMauro S. Mitochondrial encephalomyopathies: What next? J Inherit Metab Dis 1996; 19: 489-503.
6. DiMauro S, Hirano M, Bonilla E, De Vivo DC. The mitochondrial disorders. In Berg BO, ed. Principles of child neurology. New York: McGraw-Hill; 1996. p. 1201-32.
7. Campos Y, Arenas J. Genética molecular de las citopatías mitocondriales. An Esp Pediatr 1996; 83 (Supl): 293-6.
8. Wallace CD. Diseases of the mitochondrial DNA. Ann Rev Biochem 1992; 61: 1175-212.
9. Wallace DC, Lott MT. Maternally inherited diseases. In DiMauro S, Wallace DC, eds. Mitochondrial DNA in human pathology. New York: Raven Press; 1993. p. 63-83.
10. Martín MA, Campos Y, de Bustos F, del Hoyo P, Rubio JC, Arenas J. Genética molecular de las alteraciones de la cadena respiratoria mitocondrial. Rev Neurol 1998; 26 (Supl 1): S27-35.
11. Lys mutation. Cell 1990; 61: 931-7.
12. Moraes CT, Ricci E, Arnaudo E, Bonilla E, DiMauro S, Schon EA. Quantitative defects of mitochondrial DNA. In DiMauro S, Wallace DC, eds. Mitochondrial DNA in human pathology. New York: Raven Press; 1993. p. 97-108.
13. Tatuch Y, Christodolpu J, Feigenbaum A, Clark J, Wherret J, Smith C, et al. Heteroplasmic mtDNA mutation (T to G) at 8993 can cause Leigh's disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992; 50: 852-8.
14. McShane MA, Hammans SR, Sweeney M, Brockington M, Harding A, Morgan-Hughes JA. Pearson's syndrome and mitochondrial encephalopathy in a patient with a deletion of mtDNA. Am J Hum Genet 1991; 48: 39-42.
15. Shanske S, DiMauro S. Mitochondrial myopathies: biochemical aspects. Curr Top Bioenerg 1994; 17: 21-58.
16. Rubio JC, Martín MA, del Hoyo P, de Bustos F, Campos Y, Arenas J. Déficits de los complejos enzimáticos de la cadena respiratoria mitocondrial. Rev Neurol 1998; 26 (Supl 1): S15-20.
17. Friedrich T, Steinmüller A, Weiss H. The proton pumping respiratory complex I of bacteria and mitochondria and its homologue in chloroplasts. FEBS Lett 1995; 367: 107-11.
18. Walker JE. Determination of the structures of respiratory chain enzyme complexes from mammalian mitochondria. Biochim Biophys Acta 1995; 1271: 221-7.
19. Ackrell BAC, Johnson MK, Ginsalus RP, Cecchini G. Structure and function of succinate dehydrogenase and fumarate reductase. In Muller F, ed. Biochemistry of flavoenzymes. Boca Raton: CRC Press; 1992. p. 229-97.
20. Anderson S, Bankier AT, Barrell BG, de Brijin MHL, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-65.
21. Sheratt HSA. Mitochondria: structure and function. Rev Neurol (Paris) 1991; 147: 417-30.
22. DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In Rosenberg R, Prusiner S, DiMauro S, Barchi RL, eds. The molecular and genetic basis of neurological diseases. 2 ed. Boston: Butterworth-Heineman; 1997. p. 201-35.
23. Chamoles N. Citopatías mitocondriales. En Fejerman N, Fernández Álvarez E, eds. Neurología pediátrica. 2 ed. Buenos Aires: Médica Panamericana; 1997. p. 368-82.
24. DiMauro S, Andreu AL, Bonilla E. Encefalomiopatías mitocondriales; ¿Hacia dónde vamos? Rev Neurol 1999; 28: 164-8.
25. Moraes C, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda A, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989; 320: 1293-9.
26. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997; 29: 131-49.
27. Zupanc ML, Moraes CT, Shanske S, Langman CB, Ciafaloni E, DiMauro S. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndrome. Ann Neurol 1991; 29: 680-3.
28. Goto Y, Itami N, Kajii N, Tochimaru H, Endo M, Horai S. Renal tubular involvement mimicking Bartter's syndrome in a patient with Kearns-Sayre's syndrome. J Pediatr 1990; 116: 904-10.
29. Eviatar L, Shanske S, Gauthier B, Abrams C, Maytal J, Slavin M, et al. Kearns-Sayre syndrome presenting as a renal tubular acidosis. Neurology 1990; 40: 1761-3.
30. Castro-Gago M, Novo Rodríguez MaI, Eirís Puñal J. Aspectos actuales de las encefalomiopatías mitocondriales durante la niñez y adolescencia. Rev Esp Pediatr 1998; 54: 465-84.
31. Pearson HA, Lobel JS, Kocoshis SA, Kocoshis SA, Naiman JW, Windmuller J, et al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrows precursors and exocrine pancreatic dysfunction. J Pediatr 1979; 95: 976-84.
32. Rötig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F, Romero N, et al. Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy. J Clin Invest 1990; 86: 1601-8.
33. Blaw ME, Mize CE. Juvenile Pearson's syndrome. J Child Neurol 1990; 5: 187-90.
34. Santorelli FM, Barmada MA, Pons R, Zhang L, DiMauro S. Leigh-type neuropathology in Pearson's syndrome associated with impaired ATP production and novel mtDNA deletion. Neurology 1996; 47: 1320-3.
35. Campos Y, García-Silva T, Barrionuevo CR, Cabello A, Muley R, Arenas J. Mitochondrial DNA deletion in a patient with mitochondrial myopathy, lactic acidosis, stroke-like episodes (MELAS) and Fanconi's syndrome. Pediatr Neurol 1995; 13: 69-72.
36. Rötig A, Goutiéres F, Niaudet P, Rustin P, Chretien D, Guest G, et al. Deletion of mitochondrial DNA in patients with chronic tubulointerstitial nephritis. J Pediatr 1995; 126: 597-601.
37. Cormier-Daire V, Bonnefont JP, Rustin P, Maurage C, Ogier H, Schmitz J, et al. Mitochondrial DNA rearrangements with onset as chronic diarrhea with villous atrophy. J Pediatr 1994; 124: 63-70.
38. Castro-Gago M, Novo-Rodríguez MaI, Eirís-Puñal J. Encefalomiopatías mitocondriales de comienzo en la infancia y adolescencia. Rev Neurol 1998; 26 (Supl 1): S61-71.
39. Aicardi J. Diseases of the nervous system in childhood. 2 ed. Oxford: MacKeith Press; 1998.
40. Silvestri G, Ciafaloni S, Santorelli F, Shanske S, Servidei S, Graf WD, et al. Clinical features associated with the A>G transition at nucleotide 8344 of mtDNA ('MERRF mutation'). Neurology 1993; 43: 1200-6.
41. Lys gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1992; 51: 1213-7.
42. Lys gene. Eur J Hum Genet 1993; 1: 80-7.
43. Lys gene associated with myoclonus epilepsy with ragged-red fibers. Neurology 1999; 52: 377-82.
44. Howell N, Kubacka I, Smith R, Frerman F, Parks JK, Parker WD Jr. Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh's disease. Neurology 1996; 46: 219-22.
45. Campos Y, Huertas R, Esteban J, Arenas J. Mutación puntual A G 8344 del ADN mitocondrial en una familia con epilepsia mioclónica y fibres rojo-rasgadas (MERRF). Rev Diagn Biol 1993; 42: 180-3.
46. Serra G, Piccinnu R, Tondi M, Muntoni F, Zeviani M, Mastropaolo C. Clinical and EEG findings in eleven patients affected by mitochondrial encephalomyopathy with MERRF-MELAS overlap. Brain Dev 1996; 18: 185-91.
47. Lys gene associated with progressive external ophtalmoplegia and myoclonus. Neuromuscul Disord 1999; 9: 66-71.
48. Lys gene (G8363A). Am J Hum Genet 1996; 58: 933-9.
49. Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992; 31: 191-8.
50. Leu(UUR) gene. J Pediatr 1992; 120: 62-6.
51. Terauchi A, Tamagawa K, Morimatsu Y, Kobayaski M, Sano T, Yoda S. An autopsy case of mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) with a point mutation of mitochondrial DNA. Brain Dev 1996; 18: 224-9.
52. (Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.
53. (Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 1990; 173: 816-22.
54. Leu(UUR) mutation in mitochondrial encephalomyopathy, lactic acidosis and strokelike episodes (MELAS): genetic, biochemical, and morphological correlation in skeletal muscle. Am J Hum Genet 1992; 50: 934-49.
55. Goto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1991; 1097: 238-40.
56. Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J. A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 1993; 2: 1981-7.
57. Manfredi G, Schon EA, Moraes CT, Bonilla E, Berry GT, Sladky JT, et al. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul Disord 1995; 5: 391-8.
58. Sakuta R, Goto Y, Horai S, Nonaka I. Mitochondrial DNA mutations at nucleotide position 3243 and 3271 in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a comparative study. J Neurol Sci 1993; 115: 158-60.
59. Moraes CT, Ciacci F, Silvestri G, Shanske S, Sciacco M, Hirano M, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993; 3: 43-50.
60. Campos Y, Bautista J, Gutiérrez-Rivas E, Llabrés J, Lorenzo G, Arenas J. Variable clinical expression associated with mutation 3243nt of mitochondrial DNA. J Inherit Metab Dis 1994; 17: 634-5.
61. Leu(UUR) gene an etiologic hot spot? J Clin Invest 1993; 92: 2906-15.
62. Leu(UUR) mutation and complex I deficiency responsive to riboflavin. J Pediatr 1997; 130: 138-45.
63. Leu(UUR) 3254 C-to-G. Neurology 1997; 49: 598-600.
64. Verma A, Moraes CT, Shebert R, Bradley WG. A MERRF/PEO overlap syndrome associated with the mitochondrial DNA 3243 mutation. Neurology 1996; 46: 1334-6.
65. Sue CM, Bruno C, Andreu AL, Cargan A, Mendell JR, Tsao C-Y, et al. Infantile encephalopathy associated with the MELAS A3243G mutation. J Pediatr 1999; 134: 696-700.
66. Sehi A, Nishino I, Goto Y, Maegaki Y, Koeda T. Mitochondrial encephalomyopathy with 15915 mutation: clinical report. Pediatr Neurol 1997; 17: 161-4.
67. Leu(UUR) gene associated with familial myopathy. J Neurol Sci 1999; 164: 153-7.
68. Leu(UUR) gene associated with maternally inherited cardiomyopathy. Hum Mutat 1994; 3: 37-43.
69. Bruno C, Kirby MK, Koga Y, Garavaglia B, Duran G, Santorelli FM, et al. The mitochondrial DNA C3303T mutation can cause cardiomyopathy and/or skeletal myopathy. J Pediatr 1999; 135: 197-202.
70. Newman NJ. Leber's hereditary optic neuropathy. Arch Neurol 1993; 50: 540-8.
71. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994; 91: 6206-10.
72. Larsson NG, Anderson O, Holme E, Olofors A, Wahlstrom J. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol 1991; 30: 701-8.
73. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In Scriver CR, Beaudet A, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited diseases. New York: McGraw-Hill; 1995. p. 1535-611.
74. Carelli V, Ghelli A, Ratta M, Bacchilega E, Sangiorge S, Mancini R, et al. Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology 1997; 48: 1623-32.
75. De Vries DD, Went IN, Bruyin GW, Scholte HR, Hofstra RM, Bolhuis PA, et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 1996; 58: 703-11.
76. Holt IJ, Harding AE, Petty RK, Morgan Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasm. Am J Hum Genet 1990; 46: 428-33.
77. Uziel G, Moroni I, Lamantes E, Fratta GM, Ciceri E, Carrara F, et al. Mitochondrial disease associated with the T8993G mutation on the mitochondrial ATPase 6 gene: a clinical, biochemical and molecular study in six families. J Neurol Neurosurg Psychiatry 1997; 63: 16-22.
78. Santorelli FM, Shanske S, Macaya A, De Vivo DC, DiMauro S. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 1993; 34: 827-34.
79. Mak S-C, Chi C-S, Liu C-Y, Pang C-Y, Wei Y-H. Leigh syndrome associated with mitochondrial DNA 8993 T>G mutation and ragged-red fibers. Pediatr Neurol 1996; 15: 72-5.
80. Ferlin T, Landrieu P, Rambaud C, Fernández H, Dumoulin R, Rustin P, et al. Segregation of the G8993 mutant mitochondrial DNA through generations and embryonic tissues in a family at risk of Leigh syndrome. J Pediatr 1997; 131: 447-9.
81. Santorelli FM, Mak S-C, Vázquez-Memije ME, Shanke S, Kranz-Eble P, Jain KD, et al. Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatr Res 1996; 39: 914-7.
82. De Vries DD, van Engelen BGM, Gabreels FJM, Ruitenbeek W, van Dost BA. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol 1993; 34: 410-2.
83. →C mutation at nt 8993 of mitochondrial DNA in a child with Leigh's syndrome. Neurology 1994; 44: 972-4.
84. Thyagarajan D, Shanske S, Vázquez-Memije M, de Vivo D, DiMauro S. A novel mitochondrial ATPase mutation in familial bilateral striatal necrosis. Ann Neurol 1995; 38: 468-72.
85. De Meirleir L, Seneca S, Lissens W, Schoentjes E, Desprechins B. Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene. Pediatr Neurol 1995; 13: 242-6.
86. Campos Y, Martín MA, Rubio JC, Solana LG, García-Benayas C, Terradas JL, et al. Leigh syndrome associated with the T9176C mutation in the ATPase 6 gene of mitochondrial DNA. Neurology 1997; 49: 395-7.
87. Santorelli FM, Schiessel JS, Slonin AE, DiMauro S. Novel mutation in the mitochondrial DNA tRNA glycine gene associated with sudden unexpected death. Pediatr Neurol 1996; 15: 145-9.
88. Cys gene associated with mitochondrial encephalopathy. Hum Mutat 1996; 7: 158-63.
89. Cys gene mutation (A5814G): a second family with mitochondrial encephalopathy. Neuromuscul Disord 1997; 7: 156-9.
90. Verma A, Piccoli DA, Bonilla E, Berry GT, DiMauro S, Moraes CT. A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res 1997; 42: 448-54.
91. Trp gene. Ann Neurol 1997; 42: 256-60.
92. Scr(UCN) gene. Ann Neurol 1998; 44: 635-40.
93. Scr(UCN) mutation. Ann Neurol 1998; 44: 700-4.
94. Scr(UCN) gene. Neurology 1999; 52: 1905-8.
95. Campos Y, Martín MA, Rubio JC, Cabello A, Gutiérrez del Olmo MC, Arenas J. Bilateral striatal necrosis and MELAS associated with a new T3308C mutation in the mitochondrial ND1 gene. Biochem Biophys Res Commun 1997; 238: 323-5.
96. Asp gene in a child with myoclonic epilepsy and psychomotor regression. J Child Neurol 1999; 14: 610-3.
97. Andreu AL, Tanji K, Bruno C, Hadjigeorgiou GM, Sue CM, Jay C, et al. Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene. Ann Neurol 1999; 45: 820-3.
98. Bruno C, Martinuzzi A, Tang Y, Andreu AL, Pallotti F, Bonilla E, et al. A stop-codon mutation in the human mtDNA cytochrome C oxidase I gene disrupts the functional structure of complex IV. Am J Hum Genet 1999; 65: 611-20.
99. Moreadith RW, Batshaw ML, Ohnishi T, Kerr D, Knox B, Jackson D, et al. Deficiency of iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine-dinucleotide-ubiquinone oxireductase (complex I) in an infant with congenital lactic acidosis. J Clin Invest 1984; 74: 685-97.
100. Robinson BH, Ward J, Goodyer P, Beaudet A. Respiratory chain defects in the mitochondria cultured skin fibroblasts from three patients with lactic acidemia. J Clin Invest 1986; 77: 1422-7.
101. Morgan-Hughes JA, Schapira AHV, Cooper JM, Clark JB. Molecular defects on NADH-ubiquinone oxireductase (complex I) in mitochondrial diseases. J Bionerg Biomembr 1986; 20: 365-82.
102. Arts WFM, Scholte HR, Bogaard JM, Kerrebijn KF, Luyt-Houwen IEM. NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin. Lancet 1983; 2: 581-2.
103. Watmough NJ, Birch-Machin MA, Bindoft LA, Aynsely-Green A, Simpson K, Ragan CI, et al. Tissue-specific defect of complex I of the mitochondrial respiratory chain. Biochem Biophys Res Commun 1989; 160: 623-7.
104. Bet L, Bresolin N, Moggio M, Media G, Prelle A, Schapira AH. A case of mitochondrial myopathy, lactic acidosis and complex I deficiency. J Neurol 1990; 237: 399-404.
105. Tsao C, Wright FS, Boesel CP, Luquette M. Partial NADH dehydrogenase defect presenting as spastic cerebral palsy. Brain Dev 1994; 16: 393-5.
106. Fujii T, Ito M, Okuno T, Mutoh K, Nihiskmori R, Mikawa H. Complex I (reduced nicotinamide-adenine dinucleotide-coenzyme Q reductase) deficiency in two patients with probable Leigh syndrome. J Pediatr 1990; 116: 84-7.
107. DiMauro S, Bonilla E, De Vivo DC. Does the patient have a mitochondrial encephalomyopathy? J Child Neurol 1999; 14 (Suppl 1): S23-35.
108. Morris AAM, Leonard JV, Brown GK, Bidouki SK, Bindoff LA, Woodward CE, et al. Deficiency of respiratory chain complex I is a common cause of Leigh disease. Ann Neurol 1996; 40: 25-30.
109. Antozzi C, Franceschetti S, Filippini G, Barbiroli N, Savdiardo M, Fiachino F, et al. Epilepsia partialis continua associated with NADH-coenzyme Q reductase deficiency. J Neurol Sci 1995; 129: 152-61.
110. Eirís J, Rodríguez E, Pintos E, Campos Y, Castro-Gago M. Congenital ocular motor apraxia associated with myopathy, external hydrocephalus and NADH dehydrogenase deficiency. Brain Dev 1998; 20: 175-8.
111. Laubscher BL, Janzer RC, Krähenbuhi S, Hirt L, Deonna T. Ragged-red fibers and complex I deficiency in a neonate with arthrogryposis congenita. Pediatr Neurol 1997; 17: 249-51.
112. Vielhaber S, Feistner H, Schneider W, Weis J, Kunz WS. Mitochondrial complex I deficiency in a female with multiplex arthrogryposis congenita. Pediatr Neurol 2000; 22: 56-6.
113. Dionisi-Vici C, Ritenbeek W, Fariello G, Bentlage H, Wanders JA, Schägger H, et al. New familial mitochondrial encephalopathy with macrocephaly, cardiomyopathy and complex I deficiency. Ann Neurol 1997; 42: 661-5.
114. Loeffen J, Smeitink J, Trijbels JME, Janssen AJM, Triepels R, Sengers R, et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 2000; 15: 123-34.
115. Loeffen J, Smeitink J, Triepels R, Smeets R, Schuelke M, Sengers R, et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 1998; 63: 1598-608.
116. Van den Heuvel L, Ruitenbeek W, Smeets R, Gelman-Kohan Z, Elpeleg O, Loeffen J, et al. Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ) subunit. Am J Hum Genet 1998; 62: 262-8.
117. Triepels RH, van den Heuvel LP, Loeffen JLC, Buskens CAF, Smeers RJP, Rubio Gozalbo ME, et al. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol 1999; 45: 787-90.
118. Schuelke M, Smeitink J, Mariman E, Loeffen J, Plecko B, Trijbels F, et al. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 1999; 21: 260-1.
119. Sengers RCA, Fischer JC, Trijbels JMF, Ruitenbeek W, Stadhouders AM, Terlaak HJ, et al. A mitochondrial myopathy with a defective respiratory chain and carnitine deficiency. Eur J Pediatr 1983; 140: 332-7.
120. Behbehani AW, Goebel H, Osse G, Gabriel M, Langenbeck U, Berden J, et al. Mitochondrial myopathy with lactic acidosis and deficient activity of muscle succinate cytochrome c oxireductase. Eur J Pediatr 1984; 143: 67-71.
121. Riggs JE, Schochet SS Jr, Fakadej AV, Papadimitriou A, DiMauro S, Crosby TW, et al. Mitocnondrial encephalomyopathy with decreased succinate-cytochrome c reductase activity. Neurology 1984; 34: 48-53.
122. Sperl W, Ritenbeek W, Trijbels JMF. Mitochondrial myopathy with lactic acidemia, Fanconi-De Toni-Debré syndrome and a disturbed succinate: cytochrome c oxidoreductase activity. Eur J Pediatr 1988; 147: 418-21.
123. Arpa J, Campos Y, Gutiérez-Molina M, Cruz-Martínez A, Arenas J, Caminero A, et al. Benign mitochondrial myopathy with decreased succinate cytochrome c reductase activity. Acta Neurol Scand 1994; 90: 281-4.
124. Haller RG, Henriksson KG, Jorfeldt L, Hultman E, Wibom R, Sahlin K, et al. Deficiency of skeletal muscle succinate dehydrogenase and aconitase. J Clin Invest 1994; 88: 1197-206.
125. Bourgeois M, Goutiéres F, Chretien D, Rustin P, Munnich A, Aicardi J. Deficiency in complex II of the respiratory chain presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev 1992; 14: 404-8.
126. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Burgeois M, Viegas-Pequignt E, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995; 11: 144-9.
127. Ogasahara S, Engel AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 1989; 86: 2379-82.
128. 10 deficiency. Neurology 1997; 48: 1238-43.
129. 10 deficiency. J Neurol Sci 1998; 156: 41-6.
130. Birch-Machin MA, Shephered IM, Watmough NJ, Sherratt HSA, Bartlen K, Darley-Usmar VM, et al. Fatal lactic acidosis in infancy with defect of complex III of the respiratory chain. Pediatr Res 1989; 25: 553-9.
131. Kennaway NG. Defects in the cytochrome bc1 complex in mitochondrial diseases. J Bioenerg Biomembr 1988; 20: 325-52.
132. Kennaway NG, Buist NR, Darley Usmar VM, Papadimitriou A, DiMauro S, Kelley RI, et al. Lactic acidosis and mitochondrial myopathy associated with deficiency of several components of complex III of the respiratory chain. Pediatr Res 1984; 18: 991-9.
133. Reichman H, Rohkamm R, Zeviani M, Servidei S, Ricker K, DiMauro S. Mitochondrial myopathy due to complex III deficiency with normal reducible cytochrome b concentration. Arch Neurol 1986; 43: 957-61.
134. Andreu LA, Hanna MG, Reichmann H, Bruno C, Penn AS, Tanji K, et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 1999; 341: 1037-44.
135. Papadimitriou A, Neustein HB, DiMauro S, Stanton R, Bresolini N. Histiocytoid cardiomyopathy of infancy: deficiency of reducible cytochrome b in heart mitochondria. Pediatr Res 1984; 18: 1023-8.
136. Wendel U, Ruitenbeek W, Bentagle HACM, Senger RCA, Trijbels JMF. Neonatal De Toni-Debré-Fanconi syndrome due to a defect in complex III of the respiratory chain. Eur J Pediatr 1995; 154: 915-8.
137. Nigro MA, Martens ME, Awerbuch GI, Peterson PL, Lee C-P. Partial cytochrome b deficiency and generalized dystonia. Pediatr Neurol 1990; 6: 407-10.
138. Castro-Gago M, Pavón Belinchón P, Fernández Seara MaJ, Rodrigo Sáez E, Beiras Iglesias A, Pérez Sánchez A. Síndrome de West asociado a un déficit del complejo III de la cadena respiratoria mitocondrial. An Esp Pediatr 1993; 38: 355-8.
139. Sewell AC, Sperl W, Herwig J, Böbles HJ. Cirrhosis in a child with deficiency of mitochondrial respiratory-chain succinate-cytochrome c-oxidoreductase. J Pediatr 1997; 131: 166-8.
140. De Vivo DC, DiMauro S. Mitochondrial diseases. In Swaiman KF, Ashwal S eds. Pediatric neurology. 3 ed. Vol. 1. St. Louis: Mosby; 1999. p. 494-509.
141. Zafeiriou DI, Koletzko B, Mueller-Felber W, Paetzke I, Kueffer G, Jensen M. Deficiency in complex IV (cytochrome c oxidase) of the respiratory chain, presenting as a leukodystrophy in two siblings with Leigh syndrome. Brain Dev 1995; 17: 117-21.
142. Elida M, Musumeci A, Ferri R, Colamaria V, Azan G, Greco D, et al. Leigh syndrome and partial deficit of cytochrome c oxidase associated with epilepsia partialis continua. Brain Dev 1996; 18: 207-11.
143. DiMauro S, Hirano M, Bonilla E, Moraes CT, Schon EA. Cytochrome oxidase deficiency: progress and problems. In Schapira AHV, DiMauro S, eds. Mitochondrial disorders in neurology. Oxford: Butterworth-Heinemann; 1994. p. 91-115.
144. Adams PL, Lightowlers RN, Tumbull DM. Molecular analysis of cytochrome c oxidase deficiency in Leigh's syndrome. Ann Neurol 1997; 41: 268-70.
145. Zhu Z, Yao J, Johns T, Fu K, De Bie I, MacMillan C, et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998; 20: 337-43.
146. Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M, et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998; 63: 1609-21.
147. DiMauro S, Nicholson JF, Hays AP, Easthowodd AB, Papadimitiou A, Koeningsberger R, et al. Benign infantile mitochondrial myopathy due to reversible cytochrome c oxidase deficiency. Ann Neurol 1983; 14: 226-34.
148. Wada H, Woo M, Nishio H, Nagaki S, Yanagawa H, Imamura A, et al. Vascular involvement in benign infantile mitochondrial myopathy caused by reversible cytochrome c oxidase deficiency. Brain Dev 1996; 18: 263-8.
149. Tritschler FJ, Bonilla E, Lombes A, Andreetta F, Servidei S, Schneyder B, et al. Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy. An immunohistochemical approach. Neurology 1991; 41: 300-5.
150. Bardosi A, Creutzfeldt W, DiMauro S, Felgenhauer K, Friede RL, Goebel HM, et al. Myo-, neuro-, gastrointestinal encephalomyopathy (NMGIE syndrome) due to partial deficiency of cytochrome c oxidase: a new mitochondrial multisystem disorder. Acta Neuropathol 1987; 74: 248-58.
151. 3 in muscle: a report of two unrelated patients. Clin Neurol Neurosurg 1983; 85: 573-6.
152. Castro-Gago M, González-Conde V, Fernández-Seara MaJ, RodrigoSáez E, Fernández-Cebrián S, Alonso-Martín A, et al. Encefalomiopatía mitocondrial precoz por deficiencia aislada del complejo IV compatible con el síndrome de Alpers-Huttenlocher: a propósito de dos observaciones. Rev Neurol 1999; 29: 912-7.
153. Morris AAM, Singh-Kler R, Perry RH, Griffiths PD, Burt AD, Wong CP, et al. Respiratory chain dysfunction in progressive neuronal degeneration of childhood with liver disease. J Child Neurol 1996; 11: 417-9.
154. Beltran RS, Coker SB. Familial spastic paraparesis: a case of a mitochondrial disorder. Pediatr Neurosurg 1990; 16: 40-2.
155. Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernández P, et al. Spastic paraplegia and OXPHOS impairment caused by mutation in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93: 973-83.
156. Lincke CR, van den Bogert C, Nijtman LGJ, Wanders RJA, Tamminga P, Barth PG. Cerebellar hypoplasia in respiratory chain dysfunction. Neuropediatrics 1996; 27: 216-8.
157. Rubio-Gozalbo ME, Smeitink JAM, Ruitenbeek W, Laak HT, Mullaart RA, Schuelke M, et al. Spinal muscular atrophy-like picture, cardiomyopathy, and cytochrome c oxidase deficiency. Neurology 1999; 52: 383-6.
158. Williams AN, Gray RG, Poulton K, Ramani P, Whitehouse WPA. A case of Ohtahara syndrome with cytochrome oxidase deficiency. Dev Med Child Neurol 1998; 40: 568-70.
159. Zelnik N, Axeirod FB, Leshinsky E, Griebel ML, Kolodny EH. Mitochondrial encephalomyopathies presenting with features of autonomic and visceral dysfunction. Pediatr Neurol 1996; 14: 251-4.
160. Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, et al. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 1999; 23: 333-7.
161. Schotland DL, DiMauro S, Bonilla E, Scarpa A, Lee CP. Neuromuscular disorder associated with a defect in mitochondrial energy supply. Arch Neurol 1976; 33: 475-9.
162. Nagal T, Tuchiya Y, Taguchi Y, Sakuta R, Ichiki T, Nonaka I. Fatal
163. Castro-Gago M, Eirís J, Fernández-Bustillo J, Escribano D, Pintos E, Monasterio L, et al. Severe myoclonic epilepsy associated with mitochondrial cytopathy. Childs Nerv Syst 1995; 11: 630-3.
164. Castro-Gago M, González Pereira MJ, Fernández Seara MaJ, Rodicio M, Pintos E, Fuster Soler JL, et al. Forma infantil precoz de citopatía mitocondrial por déficit de los complejos I y IV de la cadena respiratoria. Rev Esp Pediatr 1993; 49: 163-7.
165. Sánchez Lastres J, Álvez F, Pintos E, Campos Y, Arenas J, Castro-Gago M. Enfermedad de Leigh secundaria a deficiencia de los complejos I, III y IV de la cadena respiratoria mitocondrial. Rev Esp Neurol 1994; 9: 29-32.
166. Castro-Gago M, Eirís Puñal J, Fernández Bustillo JM, Novo Rodríguez I, Pintos Martínez E, Peña Guitián J. Amaurosis congénita de Leber asociada a citopatía mitocondrial por déficit del complejo IV. An Esp Pediatr 1995; 42: 374-6.
167. Castro-Gago M, Pintos-Martínez E, Beiras-Iglesias A, Maroto S, Campos Y, Arenas J, et al. Leber's congenital amaurosis associated with mitochondrial dysfunction. J Child Neurol 1996; 11: 108-11.
168. Castro-Gago M, Pintos E, Maroto S, Novo I, Arenas J, Campos Y, et al. Amaurose congénitale de Leber associée avec citopathie mitochondriales. A propos de cinq observations. Paris: 24ème Réunion Annuelle de la Société Européenne de Neurologie Pédiatrique; 1996. p. 50.
169. Castro-Gago M, Alonso A, Pintos-Martínez E, Beiras-Iglesias A, Campos Y, Arenas J, et al. Congenital hydranencephalic-hydrocephalic syndrome associated with mitochondrial dysfunction. J Child Neurol 1999; 14: 131-5.
170. Castro-Gago M, Iglesias-Diz M, Eirís-Puñal J. Congenital hydranencephalic-hydrocephalic syndrome and mitochondrial dysfunction. J Child Neurol 1999; 14: 824.
171. Schatz G. The mitochondrial protein import machinery. In Sato T, DiMauro S, eds. Mitochondrial encephalomyopathies. New York: Raven Press; 1991. p. 57-73.
172. Takakubo F, Cartwright P, Hoogenraad N, Thorburn DR, Collins F, Lithgow T, et al. An amino acid substitution in the pyruvate dehydrogenase E1 affecting mitochondrial import of the precursor protein. Am J Hum Genet 1995; 57: 772-80.
173. Schapira AHV, Cooper JM, Morgan-Hughes JA, Landon DN, Clark JB. Mitochondrial myopathy with a defect of mitochondrial protein transport. N Engl J Med 1990; 323: 37-42.
174. Agsteribbe E, Huckriede A, Veenhuis M, Ruiters MHJ, Niezen-Koning KE, Skjeldal OH, et al. A fatal, systemic mitochondrial disease with decreased mitochondrial enzyme activities, abnormal ultrastructure of the mitochondria and deficiency of heat shock protein 60. Biochem Biophys Res Commun 1993; 193: 146-54.
175. Briones P, Vilaseca MA, Ribes A, Vernet A, Lluch M, Cusi V, et al. A new case of multiple mitochondrial enzyme deficiencies with decreased amount of heat shock protein 60. J Inherit Metab Dis 1997; 20: 569-77.
176. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989; 339: 309-11.
177. Zeviani M, Tiranti V. Inherited Mendelian defects. In DiMauro S, Wallace DC, eds. Mitochondrial DNA in human pathology. New York: Raven Press; 1993. p. 85-95.
178. Suomalainen A, Majander A, Haltia M, Somer H, Lönnqvist J, Savoniaus MJ, et al. Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest 1992; 90: 61-6.
179. Suomalainen A, Kaukonen J, Amati P, Timonen M, Haltia J, Weissenbach H, et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 1995; 9: 146-51.
180. Suomalainen A, Majander A, Wallin M, Setälä K, Kontula K, Leinonen H, et al. Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology 1997; 48: 1244-53.
181. Kaukonen JA, Amati P, Suomalinen A, Rötig A, Piscagua M-G, Salvi F, et al. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 1996; 58: 763-9.
182. Kaukonen J, Zeviani N, Comi GP, Piscaglia MG, Peltonen L, Suomalainen A. A third locus predisposing to multiple deletions of mtDNA in autosomal dominant progressive external ophtalmoplegia. Am J Hum Genet 1999; 65: 256-61.
183. Bohlega S, Tanji K, Santorelli FM, Hirano M, Al-Jishi A, DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996; 46: 1329-34.
184. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNG-IE): clinical, biochemical and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44: 721-7.
185. Hirano M, García-de-Yebenes J, Jones AC, Nishino I, DiMauro S, et al. Mitochondrial neurogastrointestinal encephalomyopathy syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet 1998; 63: 526-33.
186. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE: a human mitochondrial disorder. Science 1999; 283: 689-92.
187. Santorelli FM, Sciacco M, Tanji K, Shanske S, Vu TH, Golzi V, et al. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: a study of 56 patients. Ann Neurol 1996; 39: 789-95.
188. Casademont J, Barrientos A, Cardellach F, Cardellach A, Rötig JM, Grau J, et al. Multiple deletions of mtDNA in two brothers with sideroblastic anemia and mitochondrial myopathy and in their asymptomatic mother. Hum Mol Genet 1994; 3: 1945-9.
189. Pitkänen S, Merante F, McLeod R, Applegarth D, Tong T, Robinson BH. Familial cardiomyopathy with cataracts and lactic acidosis: a defect in complex I (NADH-dehydrogenase) of the mitochondria respiratory chain. Pediatr Res 1996; 39: 513-21.
190. Suomalainen A, Pateau A, Leinonen H, Majander A, Peltonen L, Somer H. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 1992; 340: 1319-20.
191. Barrientos A, Volpini V, Casademont J, Genis D, Manzanares JM, Ferrer I, et al. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA delections in families with Wolfram's syndrome. J Clin Invest 1996; 97: 1570-6.
192. Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, et al. MtDNA depletion with variable tissue expression. A novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 1991; 48: 492-501.
193. Mazziotta MR, Ricci E, Bertini E, Dionisi C, Servidei S, Burlina AB, et al. Fatal infantile liver failure associated with mitochondrial DNA depletion. J Pediatr 1992; 121: 896-901.
194. Maaswinkel-Mooij PD, van den Bogert V, Scholte HR, Onkenhout W, Brederoo P, Poorthuis BJHM. Depletion of mitochondrial DNA in the liver of a patient with lactic acidemia and hypoketotic hypoglycemia. J Pediatr 1996; 128: 679-83.
195. Bakker HD, Scholte HR, Dingemans KP, Spelbrink JN, Wijburg FA, van den Bogert C. Depletion of mitochondrial deoxyribonucleic acid in a family with fatal neonatal liver disease. J Pediatr 1996; 128: 683-7.
196. Pons R, Andreetta F, Wang CH, Vu TH, Bonilla E, DiMauro S, et al. Mitochondrial myopathy simulating spinal muscular atrophy. Pediatr Neurol 1996; 15: 153-8.
197. Castro-Gago M, Novo-Rodríguez I, García Caballero T, Campos Y, Huertas R, Arenas J. Miopatía mitocondrial por déficit de los complejos III y IV. Una observación familiar. An Esp Pediatr 1993; 38: 82-6.
198. Arenas J, Campos Y, Castro-Gago M. Depleción del ADN mitocondrial en miopatía mitocondrial por déficit de los complejos III y IV de la cadena respiratoria. An Esp Pediatr 1996; 45: 656-7.
199. Castro-Gago M, Eirís J, Novo Rodríguez MaI, Campos Y, Arenas J. Forme familière de myopathie mitochondriale avec depletion de l'ADNmt. Roma: 6ème Congrès de la Société Européenne de Neurologie Pédiatrique; 1997. p. 37.
200. Vu TH, Sciacco M, Tanji K, Nichter C, Bonilla E, Chatkupt S, et al. Clinical manifestations of mitochondrial DNA depletion. Neurology 1998; 50: 1783-90.
201. Campos Y, Martín MA, García-Silva T, del Hoyo P, Rubio JC, Castro-Gago M, et al. Clinical heterogeneity associated with mitochondrial DNA depletion in muscle. Neuromuscul Disord 1998; 8: 568-73.
202. Castro-Gago M, Martinón-Sánchez JM, Rodríguez-Núñez A, Herranz JL, Eirís-Puñal J. Severe myoclonic epilepsy and mitochondrial cytopathy. Childs Nerv Syst 1997; 13: 570-1.
203. Naviaux RK, Nyhan WL, Barshop BA, Poulton J, Markusic D, Karpinski NC, et al. Mitochondrial DNA polymerase γ deficiency and mtDNA depletion in a child with Alpers' syndrome. Ann Neurol 1999; 45: 54-8.
204. Larsson NG, Oldfors A, Holme E, Clayton DA. Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biochem Biophys Res Commun 1994; 200: 1347-81.
205. Bodemer C, Rötig A, Rustin P, Cormier V, Niaudet P, Saudubray J-M, et al. Hair and skin disorders as signs of mitochondrial disease. Pediatrics 1999; 103: 428-33.
206. Trijbels JMF, Sengers RCA, Ruitenbeck W, Fischer JC, Bakkeren JM, Janssen AJM. Disorders of the mitochondrial respiratory chain: clinical manifestations and diagnostic approach. Eur J Pediatr 1988; 148: 92-7.
207. Tulinius MH, Holme E, Kristiansson B, Larsson N-G, Olfors A. Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigations. J Pediatr 1991; 119: 242-50.
208. Breningstall GN. Approach to diagnosis of oxidative metabolism disorders. Pediatr Neurol 1993; 9: 81-90.
209. Chi C-S, Mak S-C, Shian W-J, Chen C-H. Oral glucose lactate stimulation test in mitochondrial diseases. Pediatr Neurol 1992; 8: 445-9.
210. Eirís J, Álvarez-Moreno A, Briones P, Alonso-Alonso C, Castro-Gago M. Déficit de piruvato deshidrogenasa y malformaciones cerebrales. Rev Neurol 1996; 24: 1272-5.
211. Chinnery PF, Turbull DM. Clinical features, investigations, and management of patients with defects of mitochondrial DNA. J Neurol Neurosurg Psychiatry 1997; 63: 559-63.
212. Bank W, Park J, Lech G, Chance B. Near-infrared spectroscopy in the diagnosis of the mitochondrial disorders. Biofactors 1998; 7: 243-5.
213. Muñoz A, Bautista J. Tratamiento de las enfermedades mitocondriales. Rev Neurol 1998; 26 (Supl 1): S87-91.
214. Hammans SR, Morgan-Hughes JA. Mitochondrial myopathies: clinical features, investigation, treatment and genetic counselling. In Schapira AHV, DiMauro S, eds. Mitochondrial disorders in neurology. Oxford: Butterworth-Heinemann; 1994. p. 49-74.
215. Castro-Gago M, Otero S, Novo I, Rodrigo E, Rozas I, Rodríguez-Segade S. Deficiencia de carnitina asociada a hiperamoniemia en niños a tratamiento con ácido valproico. Rev Esp Epilepsia 1988; 3: 169-72.
216. Rozas I, Camiña F, Paz JM, Alonso C, Castro-Gago M, Rodríguez-Segade S. Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues. Biochem Pharmacol 1990; 39: 181-5.
217. Castro-Gago M, Novo I, Rodríguez-Segade S. Effects of valproic acid on the urea cycle and carnitine metabolism. Int Pediatr 1990; 5: 54-7.
218. Castro-Gago M, Rodrigo E, Marwan K, Novo I, Graña MI, Camiña F, et al. Repercusión de la administración aguda de ácido valproico sobre el metabolismo de la carnitina y del amonio sanguíneo. Rev Esp Epilepsia 1990; 5: 86-90.
219. Castro-Gago M, Rodrigo E, Novo I, Camiña F, Rodríguez-Segade S. Hyperamino-acidemia in epileptic children treated with valproic acid. Childs Nerv Syst 1990; 6: 434-6.
220. Camiña F, Rozas I, Castro-Gago M, Paz JM, Alonso C, Rodríguez-Segade S. Alteration of renal carnitine metabolism by anticonvulsant. Neurology 1991; 41: 1444-8.
221. Rodrigo Sáez E, Novo Rodríguez I, Castro-Gago M, Rodríguez-Segade S, Camiña F. Estudio clínico-experimental sobre la repercusión del ácido valproico a nivel del metabolismo de la carnitina y del ciclo de la urea. Libro Premios Nutrición Infantil. Barcelona: Ancora; 1992. p. 151-97.
222. Castro-Gago M, Camiña F, Rodríguez-Segade S. Carnitine deficiency due to valproic acid. J Pediatr 1992; 120: 496.
223. Castro-Gago M, Bernabeu FA, Novo I, Camiña F, Eirís J, Rodríguez-Segade S. Efecto de los fármacos anticomiciales sobre el metabolismo renal de la carnitina. Rev Neurol 1994; 22: 646-50.
224. Castro-Gago M, Eirís-Puñal J, Novo-Rodríguez MaI, Couceiro J, Camiña F, Rodríguez-Segade S. Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine and phenobarbital. J Child Neurol 1998; 13: 546-9.
225. Taivassalo T, De Stefano N, Argov Z, Matthews PM, Chen J, Genge A, et al. Effects of aerobic training in patients with mitochondrial myopathies. Neurology 1998; 50: 1055-60.
226. Wijburg FA, Barth PG, Bindoff LA, Birch-Machin MA, van-der-Blij JF, Ruitenbeek W, et al. Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet. Neuropediatrics 1992; 23: 147-52.
227. Carroll PV, Umpleby AM, Albany E, Jackson NC, Morgan-Hughes JA, Sonksen PH, et al. Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy. Clin Endocrinol (Oxf) 1997; 47: 113-7.
228. Polak PE, Zijlstra F, Roelandt JR. Indications for pacemaker implantation in the Kearns-Sayre syndrome. Eur Heart J 1989; 10: 281-2.
229. Bussieres LM, Pflugfelder PW, Guiraudon C, Brown WF, Muñoz DG, Taylor AW, et al. Exercise responses after cardiac transplantation in mitochondrial myopathy. Am J Cardiol 1993; 71: 1003-6.
230. Calvani M, Koverech A, Caruso G. Treatment of mitochondrial diseases. In DiMauro S, Wallace DC, eds. Mitochondrial DNA in human pathology. New York: Raven Press; 1993. p. 173-97.
231. Castro-Gago M, Novo Rodríguez MaI, Eirís Puñal J. Aspectos terapéuticos actuales de las enfermedades mitocondriales. An Esp Pediatr 1996; 83 (Supl): 297-301.
232. Castro-Gago M. Tratamiento de las enfermedades neurológicas en niños y adolescentes. Barcelona: Espaxs; 1999.
233. Castro-Gago M, Novo-Rodríguez MaI, Eirís-Puñal J. Tratamiento de las enfermedades mitocondriales durante la infancia y adolescencia. Rev Neurol 1998; 26 (Supl 1): S92-8.
234. Kimura S, Ohtuki N, Nazu A, Tanaka M, Takeshita S. Clinical and radiologic improvement in mitochondrial encephalomyopathy following sodium dichloroacetate therapy. Brain Dev 1997; 19: 535-40.
235. 1 for lactic acidemia in children with MELAS syndrome. J Pediatr 1997; 131: 450-2.
236. 2. Brain Dev 1997; 19: 262-7.
237. Castro-Gago M, Rodríguez-Segade S, Beiras A, Novo I, Pombo M. Effects of allopurinol on erythrocyte membrane and purine metabolism in Duchenne muscular dystrophy. Clin Chem News 1987; 12: 52-6.
238. Castro-Gago M, Lojo S, Novo I, Del Río R, Peña J, Rodríguez-Segade S. Effects of chronic allopurinol therapy on purine metabolism in Duchenne muscular dystrophy. Biochem Biophys Res Commun 1987; 147: 152-7.
239. Camiña F, Novo-Rodríguez MaI, Rodríguez-Segade S, Castro-Gago M. Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy. Clin Chim Acta 1995; 243: 151-64. (Erratum: 1996; 252: 105).
240. Castro-Gago M, Eirís-Puñal J, Rodríguez-Nuñez A, Camiña-Darriba F, Rodríguez-Segade S, Novo-Rodríguez I. Long-term effects of xanthine-oxidase inhibitor (allopurinol) in Duchenne muscular dystrophy. Int Pediatr 1994; 9: 15-20.